Trapani D, Jin Q, Miller KD, Rugo HS, et al. Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials. Clin Breast Cancer 2024 Dec 31:S1526-8209(24)00371.
PMID: 39890560